Low-density lipoprotein decorated silica nanoparticles co-delivering sorafenib and doxorubicin for effective treatment of hepatocellular carcinoma
Combinational therapy is usually considered as a preferable approach for effective cancer therapy. Especially, combinational chemotherapies targeting different molecular targets are of particular interest due to its high flexibility as well as efficiency. In our study, the surface of silica nanopart...
Saved in:
Main Authors: | Junfeng Ye (Author), Ruoyan Zhang (Author), Wengang Chai (Author), Xiaohong Du (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeted and synergistic therapy for hepatocellular carcinoma: monosaccharide modified lipid nanoparticles for the co-delivery of doxorubicin and sorafenib
by: Duan W, et al.
Published: (2018) -
Polydopamine and peptide decorated doxorubicin-loaded mesoporous silica nanoparticles as a targeted drug delivery system for bladder cancer therapy
by: Yi Wei, et al.
Published: (2017) -
Multimodal Decorations of Mesoporous Silica Nanoparticles for Improved Cancer Therapy
by: Sugata Barui, et al.
Published: (2020) -
Functionalized Periodic Mesoporous Silica Nanoparticles for Inhibiting the Progression of Atherosclerosis by Targeting Low-Density Lipoprotein Cholesterol
by: Hao Jin, et al.
Published: (2024) -
Improved drug targeting to liver tumor by sorafenib-loaded folate-decorated bovine serum albumin nanoparticles
by: Haipeng Wang, et al.
Published: (2019)